Jason Gardner
2021 - Dianthus Therapeutics
In 2021, Jason Gardner earned a total compensation of $2.2M as President and Chief Executive Officer at Dianthus Therapeutics, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $1,377,655 |
| Salary | $545,000 |
| Other | $5,447 |
| Total | $2,228,102 |
Gardner received $1.4M in option awards, accounting for 62% of the total pay in 2021.
Gardner also received $300K in non-equity incentive plan, $545K in salary and $5.4K in other compensation.
Rankings
In 2021, Jason Gardner's compensation ranked 5,618th out of 12,415 executives tracked by ExecPay. In other words, Gardner earned more than 54.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,618 out of 12,415 | 55th |
Division Manufacturing | 2,382 out of 5,505 | 57th |
Major group Chemicals And Allied Products | 1,036 out of 2,375 | 56th |
Industry group Drugs | 925 out of 2,096 | 56th |
Industry Pharmaceutical Preparations | 666 out of 1,546 | 57th |
Source: SEC filing on May 2, 2022.
Gardner's colleagues
We found two more compensation records of executives who worked with Jason Gardner at Dianthus Therapeutics in 2021.
News
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
May 2, 2022
Marqeta CEO Jason Gardner's 2021 pay jumps 7,132% to $224M
April 25, 2022
Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
April 21, 2021
Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
April 25, 2019